Lydia Sauer

Ophthalmology

3555 West 13 Mile Road
Neuroscience Center Bldg #LL-2
Royal Oak, MI 48073

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

SURGICAL MANAGEMENT AND OUTCOMES OF LARGE HIGH MYOPIC MACULAR HOLES: Global Macular Hole Multicenter Study 3.

SURGICAL MANAGEMENT AND OUTCOMES OF LARGE HIGH MYOPIC MACULAR HOLES: Global Macular Hole Multicenter Study 3.

Journal: Retina (Philadelphia, Pa.)

Published: May 05, 2026

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.

Journal: Retina (Philadelphia, Pa.)

Published: May 05, 2026

Noninvasive optical coherence tomography biomarker for Alport syndrome, COL4-related focal segmental glomerulosclerosis, and COL4 variant interpretation.

Noninvasive optical coherence tomography biomarker for Alport syndrome, COL4-related focal segmental glomerulosclerosis, and COL4 variant interpretation.

Journal: Kidney international

Published: December 23, 2025

Asymmetric Peripheral Retinal Vascular Extension in Anti-Vascular Endothelial Growth Factor-Treated Type 1 Retinopathy of Prematurity: Disparity Between Nasal and Temporal Hemispheres.

Asymmetric Peripheral Retinal Vascular Extension in Anti-Vascular Endothelial Growth Factor-Treated Type 1 Retinopathy of Prematurity: Disparity Between Nasal and Temporal Hemispheres.

Journal: American journal of ophthalmology

Published: November 15, 2025

Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling.

Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling.

Journal: American journal of ophthalmology

Published: July 04, 2023

FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES.

FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES.

Journal: Retina (Philadelphia, Pa.)

Published: June 01, 2023

Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye.

Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye.

Journal: Ophthalmology. Retina

Published: September 18, 2022

iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.

iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.

Journal: The Journal of clinical investigation

Published: July 21, 2022

LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel).

LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel).

Journal: Retina (Philadelphia, Pa.)

Published: June 17, 2021

Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Journal: Translational vision science & technology

Published: June 10, 2021

Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.

Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.

Journal: Eye (London, England)

Published: October 14, 2020

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia.

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia.

Journal: Translational vision science & technology

Published: April 06, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026